Renovaro Biosciences Inc. (RENB)
0.81
-0.01 (-0.75%)
At close: Jan 15, 2025, 11:17 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY12 | FY11 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 42.77K | n/a | n/a | n/a |
| Cost of Revenue | 121.86K | 113.50K | 123.59K | 391.42K | 366.27K | 71.71K | 18.48K | 14.53K | 32.67K | 314.64K | n/a | n/a |
| Gross Profit | -121.86K | -113.50K | -123.59K | -391.42K | -366.27K | -71.71K | -18.48K | -14.53K | 10.10K | -314.64K | n/a | n/a |
| Operating Income | -81.64M | -38.56M | -116.08M | -23.40M | -11.92M | -10.99M | -3.24M | -2.40M | -2.12M | -2.43M | -37.09K | -29.95K |
| Interest Income | n/a | n/a | 122.04K | 13.18K | 50.30K | 73.49K | 45.82K | n/a | n/a | 5.94K | n/a | n/a |
| Pretax Income | -80.65M | -39.68M | -113.43M | -26.85M | -11.42M | -18.02M | -6.42M | -2.21M | -2.20M | -2.55M | -37.59K | -29.95K |
| Net Income | -80.65M | -39.68M | -113.43M | -26.72M | -11.42M | -18.02M | -6.31M | -2.14M | -1.74M | -2.37M | -37.59K | -29.95K |
| Selling & General & Admin | 24.56M | 15.32M | 14.33M | 7.56M | 7.12M | 8.42M | 2.60M | 2.32M | 1.33M | 2.11M | 37.09K | 29.95K |
| Research & Development | 2.71M | 4.17M | 8.37M | 15.72M | 4.69M | 2.50M | 616.96K | 62.76K | 804.19K | n/a | n/a | n/a |
| Other Expenses | 54.37M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 81.64M | 19.60M | 22.83M | 23.40M | 11.92M | 10.92M | 3.22M | 2.39M | 2.13M | 2.11M | 37.09K | 29.95K |
| Interest Expense | 1.01M | 706.96K | 372.84K | 379.61K | 104.28K | 43.00 | 143.26K | 26.26K | 2.36K | 84.55K | 497.00 | n/a |
| Selling & Marketing Expenses | 383.55K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 81.64M | 19.60M | 22.83M | 23.40M | 11.92M | 10.99M | 3.24M | 2.40M | 2.16M | 2.43M | 37.09K | 29.95K |
| Income Tax | n/a | 706.96K | 34.00 | -125.28K | 104.28K | 1.00 | -111.72K | -64.88K | -462.79K | -177.54K | n/a | n/a |
| Shares Outstanding (Basic) | 96.25M | 56.27M | 52.53M | 47.17M | 46.33M | 37.55M | 21.94M | 12.27M | 9.53M | 7.50M | 5.00M | 10.44M |
| Shares Outstanding (Diluted) | 96.25M | 56.27M | 52.53M | 47.17M | 46.33M | 37.55M | 21.94M | 12.27M | 9.53M | 7.50M | 5.00M | 10.44M |
| EPS (Basic) | -0.84 | -0.71 | -2.16 | -0.57 | -0.25 | -0.48 | -0.29 | -0.17 | -0.18 | -0.32 | -0.01 | -0.00 |
| EPS (Diluted) | -0.84 | -0.71 | -2.16 | -0.57 | -0.25 | -0.48 | -0.29 | -0.17 | -0.18 | -0.32 | -0.01 | -0.00 |
| EBITDA | -79.52M | -19.48M | -22.70M | -23.28M | -11.51M | -17.94M | -5.31M | -2.39M | -2.17M | -2.42M | -37.09K | -29.95K |
| Depreciation & Amortization | 121.86K | 113.50K | 123.59K | 123.53K | 366.27K | 71.71K | 18.48K | 14.53K | 27.39K | 45.20K | n/a | n/a |